Healthcare provider profile · identity verified

Michael A Fleming, PA-C

Physician Assistant · LYNDEN, WA · NPI 1447657671

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Lisinopril	Lisinopril	410	93
Atorvastatin Calcium	Atorvastatin Calcium	398	107
Losartan Potassium	Losartan Potassium	263	64
Omeprazole	Omeprazole	237	55
Amlodipine Besylate	Amlodipine Besylate	228	58
Levothyroxine Sodium	Levothyroxine Sodium	220	48
Metformin Hcl	Metformin Hcl	197	53
Metoprolol Succinate	Metoprolol Succinate	174	50
Tamsulosin Hcl	Tamsulosin Hcl	166	38
Furosemide	Furosemide	143	35
Gabapentin	Gabapentin	139	39
Tramadol Hcl	Tramadol Hcl	118	22
Sertraline Hcl	Sertraline Hcl	116	36
Potassium Chloride	Potassium Chloride	107	25
Albuterol Sulfate Hfa	Albuterol Sulfate	98	26
Clonazepam	Clonazepam	86	13
Simvastatin	Simvastatin	85	22
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	83	17
Metoprolol Tartrate	Metoprolol Tartrate	80	17
Rosuvastatin Calcium	Rosuvastatin Calcium	80	20
Eliquis	Apixaban	76	16
Famotidine	Famotidine	75	23
Pregabalin	Pregabalin	69	17
Carvedilol	Carvedilol	68	16
Jardiance	Empagliflozin	68	18
Allopurinol	Allopurinol	67	20
Prednisone	Prednisone	66	26
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	64	12
Metformin Hcl Er	Metformin Hcl	63	15
Pantoprazole Sodium	Pantoprazole Sodium	63	16
Warfarin Sodium	Warfarin Sodium	55	16
Celecoxib	Celecoxib	50	17
Nortriptyline Hcl	Nortriptyline Hcl	50	12
Meloxicam	Meloxicam	49	21
Finasteride	Finasteride	47	13
Hydrochlorothiazide	Hydrochlorothiazide	46	12
Glimepiride	Glimepiride	45	12
Duloxetine Hcl	Duloxetine Hcl	43	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	42	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	41	31
Lorazepam	Lorazepam	40	13
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	40	23
Clopidogrel	Clopidogrel Bisulfate	39	11
Diazepam	Diazepam	38	suppressed
Estradiol	Estradiol	38	12
Fluoxetine Hcl	Fluoxetine Hcl	38	suppressed
Fluticasone Propionate	Fluticasone Propionate	37	12
Ropinirole Hcl	Ropinirole Hcl	37	suppressed
Lactated Ringers	Ringer's Solution,lactated	36	suppressed
Alendronate Sodium	Alendronate Sodium	35	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	35	suppressed
Loperamide	Loperamide Hcl	35	suppressed
Bupropion Xl	Bupropion Hcl	34	suppressed
Buspirone Hcl	Buspirone Hcl	33	suppressed
Lovastatin	Lovastatin	33	suppressed
Spironolactone	Spironolactone	33	suppressed
Trazodone Hcl	Trazodone Hcl	32	11
Venlafaxine Hcl Er	Venlafaxine Hcl	32	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	31	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	30	suppressed
Spiriva Handihaler	Tiotropium Bromide	29	suppressed
Lamotrigine	Lamotrigine	28	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	28	suppressed
Baclofen	Baclofen	27	suppressed
Tizanidine Hcl	Tizanidine Hcl	27	suppressed
Mirtazapine	Mirtazapine	25	suppressed
Pravastatin Sodium	Pravastatin Sodium	25	suppressed
Atenolol	Atenolol	24	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	24	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	24	suppressed
Propranolol Hcl	Propranolol Hcl	24	suppressed
Symbicort	Budesonide/Formoterol Fumarate	24	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	23	21
Torsemide	Torsemide	23	suppressed
Cephalexin	Cephalexin	22	17
Morphine Sulfate Er	Morphine Sulfate	22	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	22	suppressed
Paroxetine Hcl	Paroxetine Hcl	22	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	19	suppressed
Hydralazine Hcl	Hydralazine Hcl	19	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	18	suppressed
Ibu	Ibuprofen	18	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	18	suppressed
Methocarbamol	Methocarbamol	18	suppressed
Prazosin Hcl	Prazosin Hcl	18	suppressed
Xarelto	Rivaroxaban	18	suppressed
Spiriva Respimat	Tiotropium Bromide	17	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	17	suppressed
Topiramate	Topiramate	17	suppressed
Ventolin Hfa	Albuterol Sulfate	17	suppressed
Digoxin	Digoxin	16	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	16	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	16	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	16	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	15	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Oxycodone Hcl	Oxycodone Hcl	15	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	15	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	15	suppressed
Rizatriptan	Rizatriptan Benzoate	15	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	14	suppressed
Cilostazol	Cilostazol	14	suppressed
Ibuprofen	Ibuprofen	14	suppressed
Myrbetriq	Mirabegron	14	suppressed
Terbinafine Hcl	Terbinafine Hcl	14	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	13	suppressed
Arnuity Ellipta	Fluticasone Furoate	13	suppressed
Breyna	Budesonide/Formoterol Fumarate	13	suppressed
Bupropion Hcl	Bupropion Hcl	13	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	13	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	13	suppressed
Ezetimibe	Ezetimibe	13	suppressed
Glipizide	Glipizide	13	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	13	suppressed
Methadone Hcl	Methadone Hcl	13	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	13	suppressed
Citalopram Hbr	Citalopram Hydrobromide	12	suppressed
Incruse Ellipta	Umeclidinium Bromide	12	suppressed
Ozempic	Semaglutide	12	suppressed
Valproic Acid	Valproic Acid (As Sodium Salt)	12	suppressed
Alprazolam	Alprazolam	11	suppressed
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	11	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	11	suppressed
Novolin R Flexpen	Insulin Regular, Human	11	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error